Gamgee
New accelerator entry · 2026-07-22 · the record
In their words
Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved Gamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next
What the record says
Founder at Gamgee Technologies (YC S26), building personalised mRNA cancer vaccines. Gamgee grew out of my work using AI and genomics to help my dog Rosie fight cancer. Previously co-founded Core Intelligence, building applied AI systems across startups and enterprise, and helped grow Australia’s AI community through DSAI. Background in ML, data science and electrical and computer systems engineering
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
Against the 209 companies on file from Summer 2026. Median team 2, largest 30.
The nearest companies on file from the same batch, side by side with this one.
| Company | Batch | Sectors | Listed |
|---|---|---|---|
| Frontier Computing | Summer 2026 | Artificial Intelligence, Hard Tech, Hardware | 2026-08-31 |
| Ethos Space Resources | Summer 2026 | Hard Tech, Exascale Computing, Energy | 2026-08-23 |
| Spectre Intelligence | Summer 2026 | Biotech, Investing, Trading | 2026-08-22 |
| Edgerun | Summer 2026 | Robotics, Defense | 2026-08-21 |
| Allia Health | Summer 2026 | Artificial Intelligence, Healthcare, Mental Health | 2026-08-19 |
| Gamgee (this page) | Summer 2026 | Biotech, Genomics, Oncology | 2026-07-22 |
Click a column heading to sort. Comparison is against records held here, not against every company that exists.
The full profile
The rest of this profile is open on any paid or trial plan
It costs no credits. It is a plan check and nothing else.
- Source Check — verify Paul Conyngham's other claims against the registers that hold them.
- INVEST — compare this company against the peers above, on the numbers.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Paul Conyngham for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist GamgeeYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Gamgee: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry. Figures are read directly from the source record; names have not been matched against other people.